|
|
![]() |
![]() |
Sitemap
|
||
|
At the heart of Optimed’s activity, Phase I and Phase IIa studies have helped to earn its reputation as a world specialist. In order to obtain the best quality for your studies, OPTIMED has two different Clinical Research Units:
Our Clinical Research Unit in Grenoble currently comprises 60 beds, including a 12-bed intensive monitoring section and up-to-date equipment : ECG, Telemetry, Holter ECG, BP Monitoring, SpO2 Monitoring, Platelet Aggregation, EEG, Psychometric Tests, Respiratory Tests... This Clinical Research Unit is managed by Yves Donazzolo, MD, MSc, Clinical Pharmacologist, Medical Director, and Mathilde Latreille-Barbier, MD, Head of Clinical Trials. The structure in Lyon, managed by Yves Donazzolo, MD, situated in the heart of a main scientific and medical environment in France, is particularly adapted to early drug development.
OPTIMED Clinical Research can undertake many types of studies in early development :
Our organization ensures the best management of your trials in the most secure conditions. Whatever the complexity and the field of the study involved, we set up:
Our location, close to the University of Grenoble (500 000 inhabitants, 60 000 students), allows us to take advantage of a large pool of healthy volunteers and specific populations (diabetics, dyslipidemic subjects, overweight persons, subjects with high blood pressure,…).
|
||
|
Optimed - 1 rue des Essarts, 38610 Gières, France - Tel
: +33 0(4) 38 37 27 40
|
||